SARMs SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ.
Up to now, no side effects have been observed with SR9011, so it may be seen as an extremely safe compound. Moreover, just like in the case of other SARMS, SR9009 is not liver toxic, but there is a need for liver supporting supplements when using it. N2Guard at 3-5 capsules per day will be sufficient liver and kidney support.
Hot Tags: sr9011, China, manufacturers, suppliers, factory, wholesale, cheap, price, customized, buy, bulk, high quality, in stock